Internal Medicine, Endocrinology, Diabetes, & Metabolism · Elk Grove, CA
NPI
1427234012
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
8220 Wymark Dr Ste 200
Elk Grove, CA, 95757
Phone (916) 667-0600
Groups this clinician bills Medicare through
Medicare paid, 2024
$410K
15,725 services
Medicare patients, 2024
778
Average age 72
Drug cost, 2024
$5.0M
7,502 prescriptions
Company payments, 2025
$178
From 5 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Adeela N Ansari was code J0897 (injection, denosumab, 1 mg), 9,540 times for 105 patients. In total Adeela N Ansari billed 15,725 services in 16 codes, and Medicare paid $410K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 9,540 | 105 | $20.40 | $195K |
| 99214 Office E&M - Established | Office | 1,207 | 653 | $101.38 | $122K |
| 95251 Test - Miscellaneous | Office | 342 | 135 | $27.91 | $9,547 |
| 99215 Office E&M - Established | Office | 189 | 134 | $142.10 | $27K |
| 96372 Injection Administration | Office | 178 | 107 | $13.03 | $2,319 |
| 83036 Blood Count | Office | 102 | 80 | $9.52 | $971 |
| 99204 Office E&M - New | Office | 67 | 67 | $136.53 | $9,148 |
| 99213 Office E&M - Established | Office | 55 | 51 | $65.85 | $3,622 |
| 99205 Office E&M - New | Office | 30 | 30 | $164.43 | $4,933 |
By year: 2022 $243K for 6,369 services; 2023 $341K for 13,680 services; 2024 $410K for 15,725 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83036 Blood Count | 102 | 80 | $9.52 | $971 |
Medicare prescription drug claims, 2024
In 2024, the drug Adeela N Ansari prescribed most often to Medicare patients was Levothyroxine Sodium, with 793 prescriptions and refills. In total Adeela N Ansari wrote 7,502 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 793 | 2,199 | 232 | $14K |
| Ozempic Semaglutide | 653 | 1,003 | 150 | $952K |
| Jardiance Empagliflozin | 307 | 682 | 84 | $378K |
| Mounjaro Tirzepatide | 296 | 373 | 54 | $385K |
| Synthroid Levothyroxine Sodium | 282 | 728 | 75 | $32K |
| Pioglitazone Hcl Generic | 202 | 480 | 56 | $2,796 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 201 | 537 | 79 | $38K |
| Metformin Hcl Er Metformin Hcl | 195 | 517 | 60 | $2,029 |
| Trulicity Dulaglutide | 192 | 310 | 40 | $292K |
| Atorvastatin Calcium Generic | 190 | 506 | 58 | $2,347 |
| Glipizide Er Glipizide | 188 | 540 | 63 | $2,878 |
| Metformin Hcl Generic | 180 | 473 | 55 | $2,042 |
| Liothyronine Sodium Generic | 180 | 424 | 43 | $7,689 |
| Alendronate Sodium Generic | 140 | 366 | 50 | $1,437 |
| Synjardy Xr Empagliflozin/Metformin Hcl | 130 | 280 | 34 | $148K |
Brand drugs: 3,644 claims; generic drugs: 3,366 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Adeela N Ansari $178 ($178 in general payments such as food, travel and fees) from 5 companies. The largest payer was Sequel Med Tech, LLC with $82.45.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.